Family Planning Research Institute, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Curr Med Sci. 2018 Feb;38(1):191-198. doi: 10.1007/s11596-018-1864-7. Epub 2018 Mar 15.
This study was designed to evaluate the effects of testosterone supplementation (TS) on body composition in patients with HIV and the side effects of TS. A comprehensive literature search strategy was used to retrieve relevant randomized controlled trials (RCTs) examining the effects of TS on body composition. Atotal of 14 eligible studies were included, enrolling 388 and 349 randomized patients in TS and control groups, respectively. The quality of studies included was assessed, and data on total body weight (BW), lean body mass (LBM), fat mass (FM), serum total testosterone (TT), free testosterone (FT) levels, and adverse events were extracted and analyzed using Review Manager software 5.3. Meta-analysis results showed that TS was associated with a small but significant modification in total BW, serum TT, and FT levels in HIV-infected patients and in patients given various drug administrations. TS also significantly increased LBM in male patients, but no significant difference in LBM was observed between female counterparts treated with TS or not. Conversely, TS relative to placebo did not lead to a significant reduction in FM. No significant difference was observed between the two groups in terms of adverse effects. Our findings suggested that TS may be recommended to improve body composition in patients with HIV-related weight loss. However, owing to the high heterogeneity across included trials, further evaluations using large-scale, multi-center, blinded RCTs are needed.
这项研究旨在评估睾酮补充治疗(TS)对 HIV 患者身体成分的影响及其副作用。采用全面的文献检索策略,检索了评估 TS 对身体成分影响的相关随机对照试验(RCT)。共纳入了 14 项符合条件的研究,分别纳入了 388 名和 349 名接受 TS 和对照组治疗的随机患者。评估了研究的质量,并使用 Review Manager 软件 5.3 提取和分析了关于总体体重(BW)、瘦体重(LBM)、体脂肪量(FM)、血清总睾酮(TT)、游离睾酮(FT)水平和不良事件的数据。Meta 分析结果表明,TS 与 HIV 感染患者和接受各种药物治疗的患者的总 BW、血清 TT 和 FT 水平的微小但显著的改变有关,TS 还显著增加了男性患者的 LBM,但接受 TS 治疗的女性患者的 LBM 与未接受治疗的女性患者相比没有显著差异。相反,与安慰剂相比,TS 并不能显著减少 FM。两组之间在不良反应方面没有观察到显著差异。我们的研究结果表明,TS 可能有助于改善与 HIV 相关体重减轻的患者的身体成分。然而,由于纳入的试验存在高度异质性,需要使用大规模、多中心、盲法 RCT 进行进一步评估。